INS and gestational diabetes: Our findings indicate that in insulin-treated GDM placentas, mTOR activation is more pronounced, whereas AMPK upregulation is more evident in diet-managed pregnancies, suggesting a fundamental difference in metabolic adaptation between these treatments.